FAANG stocks fail to shine last week despite NASDAQ’s jump; 3 of the 5 big tech shares tumble

The holiday-shortened previous week saw the NASDAQ index gain 1% overall, after having suffered a steep fall during the initial hours of trade on Monday morning. The star constituents of the index — the FAANG stocks — witnessed a mixed bag of a week, with some gaining and others losing. So far this year, FAANG stocks have gained 50% on average, outperforming the benchmark NASDAQ index. Apple has been the best stock so far this year among the big-tech names that make up the FAANG stock list.

Facebook in the previous week registered a 3.3% fall as it failed to recover after Monday’s fall and only added to the losses. At the end of the trading session Thursday, the stock was quoting a price of $267.4 per share. During the week, reports claimed that Facebook has shut one of its intellectual property units in Ireland. The unit was claimed to be a tax-saving mechanism used by the social media behemoth. Another news around Facebook that hogged the limelight this past week was the news of Mark Zuckerberg selling 44,750 shares of the company for a total amount of $12.2 million.

The manufacturer of the iPhone, Apple, had a way better week than Facebook as stock price gained 4.2%. This stock movement came in a week when reports claimed that the company was planning to make electric vehicles by 2024. The news of Apple preparing to launch a car by 2024 was reported by Reuters, they said it is most likely the passenger car of the company will be powered by its own battery technology. Stocks of the technology giant closed at $131.97 per share last week.

Amazon was also one of the laggards in the previous week. Jeff Bezos’ firm saw it stock price slip 0.90% in the week to close at $3,172.69 per share. Streaming service Netflix was also in the red last week, slipping 3.7%. The Co-CEO of the frim, Reed Hastings has sold 437,311 shares of the firm this month for $527 per share, according to reports. The total stake sale value was $230.6 million. This comes less than a month after Reed Hastings had sold over 213,000 shares of the firm.

Technology giant Google recovered sharply from the initial fall in the week gone by and ended flat with a positive bias. Shares of the firm closed at $1,734.16 per share. Since December 2, shares of Google are down 5%.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider and Best SEBI registered stock advisory company

info@eqwires.com

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

PVR fundamentals intact despite near-term hiccups

PVR has scheduled a board meeting on December 18 to consider raising funds through issue of equity (or other instruments) by way of QIP (or other modes). We believe that the company is adequately funded to sustain operations for 6-7 months even if occupancy remains subdued and cash burn elevated at current levels. Additional funding would help reduce debt to enable investments in organic/inorganic opportunities post-Covid, or in event of resurgence of Covid-19.

PVR had liquidity of Rs 5.5 billion as at end-October 2020. It has to repay debt of Rs 1 billion by March 2021. As per our estimate, PVR is incurring Ebitda loss of Rs 500-600 million/month and interest expense of Rs 110 million/month at present (from November 2020).

Cash burn is higher (on expected lines) versus 1HFY21, as operations have resumed at subdued occupancy pending release of key movies. PVR is adequately funded to sustain operations for 6-7 months even if one assumes cash burn to continue at the current run rate.

PVR’s gross/net debt is about Rs 15 billion/Rs 10 billion as of date; equity fund raise would reduce leverage enabling PVR to invest in organic and inorganic growth opportunities post-Covid. We note that PVR raised Rs 3 bn in August 2020 through a rights issue.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider and Best SEBI registered stock advisory company

info@eqwires.com

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Burger King India shares fall, hit 10% lower circuit; what should investors do now?

Burger King India share price sharply fell in the afternoon deals today after surging for the last three days. The stock fell to hit the 10 per cent lower circuit at Rs 179.35 apiece today afternoon, after rising in the morning to hit the upper circuit. In the morning deals, Burger King shares were locked in the 10 per cent upper circuit. The company’s market capitalisation has also fallen to Rs 6,844.98 crore from Rs 8,363.96 crore in the morning.

According to an analyst, the rally in Burger King India shares was beyond expectations, and the stock became much more expensive above Rs 200 levels. “The expected profit booking is on cards. The listing day high of 135 may be tested soon. Below 135 one should not hold it in the portfolio,” Vishal Wagh, Head of Research, Bonanza Portfolio Ltd, told Financial Express Online.

Burger King India made stock market debut earlier this week with 92 per cent premium over the issue price of Rs 60 apiece. At the current level, Burger King shares are up 55 per cent from the listing price of Rs 115.35 per share, and 199 per cent up from the IPO price. Burger King India’s Rs 810-crore initial public offer was subscribed a massive 156.65 times during the three-day bidding process. During the IPO process, most of the research and brokerage firms had recommended to ‘subscribe’ to Burger King India IPO for the listing gains.

Out of the 12 IPOs that the stock markets witnessed so far this year, Burger King India is among the top four IPOs. From the listing day, Route Mobile shares have gained 221.6 per cent, Happiest Minds Technologies 94.7 per cent while Rossari Biotech stock price surged 94 per cent.

Meanwhile, Mrs Bectors Food Specialities’ Rs 540-crore IPO has also witnessed strong demand from investors across categories so far on the last day of the bidding.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider and Best SEBI registered stock advisory company

info@eqwires.com

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Laxmi Organic to launch Rs 800-cr IPO following strong listing by Rossari Biotech, Chemcon Speciality

Laxmi Organic Industries is set to raise Rs 800 crore through initial public offer (IPO). The speciality chemicals manufacturer has filed preliminary papers with the capital market regulator Securities and Exchange Board of India (Sebi). Laxmi Organic Industries’ issue will comprise fresh issue of shares aggregating to Rs 500 crore and an offer-for-sale (OFS) worth Rs 300 crore by the promoter Yellow Stone Trust, according to the draft red herring prospectus (DRHP) filed.

The book running lead managers to the Mumbai-based Laxmi Organic are Axis Capital Ltd and DAM Capital Advisors Ltd (formerly known as IDFC Securities Limited), while the registrar is Link Intime India Private Ltd. Laxmi Organic Industries’ plan comes after the recent success and fundraising by specialty chemical companies, Rossari Biotech and Chemcon Specialty Chemicals, which were subscribed almost 80 times and 149 times respectively. Moreover, Chemcon Speciality Chemicals has witnessed the best share market listing, gaining 114 per cent from the IPO price, so far in 2020.

Laxmi Organic Industries is a leading manufacturer of acetyl intermediates and specialty intermediates. According to the draft red herring prospectus (DRHP), net proceeds from the issue will be utilised for setting up of a manufacturing facility for fluoro specialty chemicals, working capital requirement, and for the purchase of plant and machinery for augmenting infrastructure development. In addition, funds would be used for prepayment or repayment of all or a portion of outstanding loans, besides general corporate purposes. The company will not receive any proceeds from the offer-for-sale. The company has a global presence with customers in over 30 countries including China, Netherlands, Russia, Singapore, United Arab Emirates (UAE), United Kingdom and the United States of America.

The two recently listed specialty chemical companies, Rossari Biotech Ltd shares were trading at Rs 826.60 apeiece, up 0.89 per cent, while Chemcon Speciality Chemicals Ltd shares ended 0.79 per cent up at Rs 432.50 apiece. In comparison, S&P BSE Sensex ended at 46,666, up 0.87 per cent, at an all-time high closing level.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider and Best SEBI registered stock advisory company

info@eqwires.com

Call: +91 9624421555 / +91 9624461555

www.eqwires.com